Table 1 Patient characteristics
Overall | Patients w/ PD (n = 23) | Patients w/o PD (n = 65) | p value | |
|---|---|---|---|---|
Age (years) | 72.35 ± 8.57 | 75.7 ± 6.96 | 71.1 ± 8.81 | 0.11 |
Female patients (%) | 66 (75.0%) | 17 (73.9%) | 49 (75.4%) | 0.89 |
Fracture type (AO/OTA)* | ||||
Type A | 40 (45.5%) | 11 (47.8%) | 29 (44.6%) | 0.41 |
Type B | 19 (21.6%) | 1 (4.3%) | 18 (27.7 %) | 0.14 |
Type C | 29 (33.0%) | 11 (47.8%) | 18 (27.7%) | 0.67 |
ASA grade | 0.78 | |||
Class I/II | 9 (10.2%) | 2 (8.7%) | 7 (10.8%) | |
Class III/IV | 79 (89.8%) | 21 (91.3%) | 58 (89.2%) | |
Smoking history | 16 (18.2%) | 5 (21.7%) | 11 (16.9%) | 0.61 |
Comorbidities | ||||
CAD | 13 | 3 | 10 | 0.54 |
DM | 17 | 2 | 15 | 0.11 |
CKD | 10 | 3 | 7 | 0.52 |
Osteoporosis | 20 | 9 | 11 | 0.03 |
PD duration (months) | X | 16.3 ± 2.1 | X | X |
Follow-up duration (months) | 8.83 ± 12.52 | 6.57 ± 6.56 | 9.63 ± 14.0 | 0.18 |